Received: 15 December 2018
Accepted: 23 August 2019
First Online: 28 August 2019
Ethics approval and consent to participate
: Patients eligible in the current study were enrolled in the ACCORD trial, a prospective multicenter, randomized, open-labelled, non-comparative phase II trial [CitationRef removed]. The ACCORD study was approved by ethics committee of the Kremlin-Bicêtre hospital and all patients provided informed written consent (clinicaltrials.gov identifier NCT00423696). The additional analyses of clinical data and interpretation of body composition from CT images in the current study were approved by the Gustave Roussy independent ethics committees.
: Not applicable.
: The authors declare that they have no competing interests.